High incidence of thrombotic complications early after liver transplantation for familial amyloidotic polyneuropathy

被引:27
|
作者
Bispo, Miguel [1 ]
Marcelino, Paulo [1 ]
Freire, Antonio [2 ]
Martins, Americo [2 ]
Mourao, Luis [1 ]
Barroso, Eduardo [2 ]
机构
[1] Curry Cabral Hosp, Intens Care Unit, Lisbon, Portugal
[2] Curry Cabral Hosp, Liver Transplant Ctr, Lisbon, Portugal
关键词
early thrombotic complications; familial amyloidotic polyneuropathy; hepatic artery thrombosis; orthotopic liver transplantation; HEPATIC-ARTERY THROMBOSIS; DOPPLER ULTRASOUND; ADULT; EXPERIENCE; REGISTRY;
D O I
10.1111/j.1432-2277.2008.00737.x
中图分类号
R61 [外科手术学];
学科分类号
摘要
Early thrombotic complications are critical causes of in-hospital morbidity after orthotopic liver transplantation (OLT), potentially culminating in graft loss. The aim of this study was to retrospectively analyse these complications, trying to identify associated independent risk factors. This retrospective analysis included 223 OLTs performed on 213 patients, in a 30-month period. Eighty-six OLTs were performed on familial amyloidotic polyneuropathy (FAP) patients. Preoperative details (primary diagnosis and Child-Turcotte-Pugh classification, when applicable), surgical features (including type of arterial reconstruction), postoperative variables and outcome were analysed. The observation period ended 30 days post-OLT, until discharge or in-hospital death. Early thrombotic complications were diagnosed in 16 cases (7.2%), affecting mainly FAP patients (n = 12). Hepatic artery thrombosis (HAT) was the most frequent early thrombotic event (n = 12): incidence in FAP patients 11.6% (n = 10) versus incidence in non FAP patients 1.5% (n = 2), P = 0.001. By logistic regression analysis, FAP turned out to be an independent risk factor for early thrombotic complications, and specifically for HAT. The type of arterial reconstruction and other analysed surgical and medical factors did not influence early HAT occurrence. In conclusion, FAP was identified in this study as an independent risk factor for early HAT, a new datum not yet described in the literature.
引用
收藏
页码:165 / 171
页数:7
相关论文
共 50 条
  • [41] De novo amyloid synthesis in ocular tissue in familial amyloidotic polyneuropathy after liver transplantation
    Ando, Y
    Ando, E
    Tanaka, Y
    Yamashita, T
    Tashima, K
    Suga, M
    Uchino, M
    Negi, A
    Ando, M
    TRANSPLANTATION, 1996, 62 (07) : 1037 - 1038
  • [42] Marked cardiomegaly in a patient with familial amyloidotic polyneuropathy after orthotopic liver transplantation: a case study
    Sakashita, Naomi
    Kagawa, Seiko
    Date, Risako
    Ueno, Tatsuro
    Nakagawa, Takenobu
    Yamashita, Taro
    Obayashi, Konen
    Ohshima, Toshinori
    Ueda, Mitsuharu
    Horiguchi, Hidehisa
    Ando, Yukio
    Takeya, Motohiro
    PATHOLOGY INTERNATIONAL, 2013, 63 (05) : 260 - 265
  • [43] Accelerating restrictive cardiomyopathy after liver transplantation in a patient with familial amyloidotic polyneuropathy: A case report
    Robin J.
    Meyers S.
    Nahlawi M.
    Puthumana J.
    Lomasney J.
    Mehlman D.
    Rigolin V.
    Davidson C.
    Journal of Medical Case Reports, 2 (1)
  • [44] LIVER-TRANSPLANTATION AS A THERAPY FOR FAMILIAL AMYLOIDOTIC POLYNEUROPATHY (FAP), PORTUGUESE TYPE
    MONTEIRO, E
    MORBEY, A
    VELOSO, J
    FREIRE, A
    COSTA, PP
    LUIS, MLS
    HEPATOLOGY, 1994, 20 (04) : A120 - A120
  • [45] The Coimbra University Hospital experience in liver transplantation in patients with familial amyloidotic polyneuropathy
    Perdigoto, R
    Furtado, AL
    Furtado, E
    Oliveira, FJ
    Geraldes, B
    Mota, O
    Ferrao, J
    Tome, L
    Viana, J
    TRANSPLANTATION PROCEEDINGS, 2003, 35 (03) : 1125 - 1125
  • [46] Liver mitochondrial function in familial amyloidotic polyneuropathy
    Silva, O. Castro e
    Sankarankutty, A. K.
    Souza, M. E. J.
    Picinato, M. A. N. C.
    Fina, C. F.
    Jordani, M. C.
    Mente, E. D.
    Cagnolatti, D.
    Teixeira, A. C.
    Souza, F. F.
    Martinelli, A. L. C.
    Rondon, L. Z.
    TRANSPLANTATION PROCEEDINGS, 2008, 40 (03) : 771 - 773
  • [47] LIVER-TRANSPLANTATION FOR THE TREATMENT OF TYPE-I FAMILIAL AMYLOIDOTIC POLYNEUROPATHY
    ANDREU, FRL
    MUNARQUES, M
    PARRILLA, P
    SORIANO, JBE
    COSTA, PP
    COSTA, PMP
    ALMEIDA, MR
    PONS, JA
    ROBLES, R
    SANCHEZBUENO, F
    RAMIREZ, P
    ACOSTA, F
    IBANEZ, JV
    MEDICINA CLINICA, 1993, 101 (15): : 581 - 583
  • [48] TREATMENT OF A JAPANESE PATIENT WITH FAMILIAL AMYLOIDOTIC POLYNEUROPATHY WITH ORTHOTOPIC LIVER-TRANSPLANTATION
    ANDO, Y
    TASHIMA, K
    TANAKA, Y
    NAKAZATO, M
    ERICZON, BG
    DURAJ, FF
    SAKASHITA, N
    KIMURA, E
    ANDO, E
    YONEHARA, T
    YAMASHITA, T
    NAKAMURA, M
    UCHINO, M
    ANDO, M
    INTERNAL MEDICINE, 1994, 33 (11) : 730 - 732
  • [49] Plasma corticotropin levels in patients with familial amyloidotic polyneuropathy during liver transplantation
    Diaz, J
    Acosta, F
    Fuente, T
    Moreno, J
    Carbonell, LF
    Parrilla, P
    CLINICAL BIOCHEMISTRY, 1998, 31 (08) : 689 - 691
  • [50] Results of liver transplantation for familial amyloidotic polyneuropathy type 1 in Brazil.
    Bittencourt, PL
    Cançado, ELR
    Farias, AO
    Leitao, RMC
    Marcchiori, PE
    Ramires, JAF
    Massarollo, PCB
    Mies, S
    Raia, S
    HEPATOLOGY, 1998, 28 (04) : 350A - 350A